Transgene Biotek

{
  "main_header": {
    "sid": 408336,
    "name": "Transgene Biotek",
    "stock_name": "Transgene Biotek",
    "full_name": "Transgene Biotek Ltd",
    "name_url": "stocks-analysis/transgene-biotek",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.06",
    "chg": 0.02,
    "chgp": "0.66%",
    "dir": 1,
    "prev_price": "3.04",
    "mcapval": "24.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526139,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE773D01018",
    "curr_date": "Jun 09, 03:30 PM",
    "curr_time": "08:08 AM",
    "last_traded_at": "Jun 09, 03:30 PM IST",
    "bse_nse_vol": "13.99 k",
    "exc_status": "Active",
    "traded_date": "Jun 09, 2026",
    "traded_date_str": "2026 06 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transgene-biotek-408336-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 79,
    "sid": "408336",
    "stock_news_url": "https://www.marketsmojo.com/news/transgene-biotek-408336"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Jun-2026",
      "details": "Newspaper Advertisement of Financial Results under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting And Submission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31 2026",
      "datetime": "29-May-2026",
      "details": "Audited Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31 2026",
      "datetime": "29-May-2026",
      "details": "This has reference to our letter dated May 13 2026 The Board of Directors of the Company at their meeting held on May 29 2026 have resolved as follows: Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the following: a) Audited Financial Results (Standalone and Consolidated) of the Company for the fourth quarter and financial year ended March 31 2026. b) Report of the Auditors on the Audited Financial Results both for (Standalone and Consolidated) financial statements for the financial year ended March 31 2026. c) Declaration pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for Consolidated and Standalone Financial Statements for the Financial Year ended March 31 2026. The meeting of the Board of Directors of the Company commenced at 11.00 AM and concluded at 11.30 AM. We kindly request you to take the above said on record.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News